About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Glioblastoma Multiforme (GBM) Treatment Market Size, Share and Forecast by 2031
Glioblastoma Multiforme (GBM) Treatment Market
Glioblastoma Multiforme (GBM) Treatment Market

Glioblastoma Multiforme (GBM) Treatment Market Size, Share & Trends Analysis Report By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy), By Drugs (Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54835DR
Last Updated : 21,Aug 2023
Author : Straits Research
Starting From
USD 995
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Glioblastoma Multiforme (GBM) Treatment Market, By Treatment (2021-2031)
    1. Surgery
    2. Radiation Therapy
    3. Chemotherapy
    4. Targeted Therapy
    5. Tumor Treating Field (TTF) Therapy
    6. Immunotherapy
  2. Glioblastoma Multiforme (GBM) Treatment Market, By Drugs (2021-2031)
    1. Temozolomide
    2. Bevacizumab
    3. Lomustine
    4. Carmustine Wafers
    5. Others
  3. Glioblastoma Multiforme (GBM) Treatment Market, By End-User (2021-2031)
    1. Hospitals
    2. Clinics
    3. Ambulatory Surgical Centers
    1. North America
      1. North America Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
        1. Surgery
          1. Radiation Therapy
            1. Chemotherapy
              1. Targeted Therapy
                1. Tumor Treating Field (TTF) Therapy
                  1. Immunotherapy
                  2. North America Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                    1. Temozolomide
                      1. Bevacizumab
                        1. Lomustine
                          1. Carmustine Wafers
                            1. Others
                            2. North America Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                              1. Hospitals
                                1. Clinics
                                  1. Ambulatory Surgical Centers
                                  2. U.S.
                                    1. U.S. Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                      1. Surgery
                                        1. Radiation Therapy
                                          1. Chemotherapy
                                            1. Targeted Therapy
                                              1. Tumor Treating Field (TTF) Therapy
                                                1. Immunotherapy
                                                2. U.S. Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                  1. Temozolomide
                                                    1. Bevacizumab
                                                      1. Lomustine
                                                        1. Carmustine Wafers
                                                          1. Others
                                                          2. U.S. Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                            1. Hospitals
                                                              1. Clinics
                                                                1. Ambulatory Surgical Centers
                                                              2. Canada
                                                            2. Europe
                                                              1. Europe Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                1. Surgery
                                                                  1. Radiation Therapy
                                                                    1. Chemotherapy
                                                                      1. Targeted Therapy
                                                                        1. Tumor Treating Field (TTF) Therapy
                                                                          1. Immunotherapy
                                                                          2. Europe Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                            1. Temozolomide
                                                                              1. Bevacizumab
                                                                                1. Lomustine
                                                                                  1. Carmustine Wafers
                                                                                    1. Others
                                                                                    2. Europe Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                      1. Hospitals
                                                                                        1. Clinics
                                                                                          1. Ambulatory Surgical Centers
                                                                                          2. U.K.
                                                                                            1. U.K. Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                              1. Surgery
                                                                                                1. Radiation Therapy
                                                                                                  1. Chemotherapy
                                                                                                    1. Targeted Therapy
                                                                                                      1. Tumor Treating Field (TTF) Therapy
                                                                                                        1. Immunotherapy
                                                                                                        2. U.K. Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                          1. Temozolomide
                                                                                                            1. Bevacizumab
                                                                                                              1. Lomustine
                                                                                                                1. Carmustine Wafers
                                                                                                                  1. Others
                                                                                                                  2. U.K. Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                    1. Hospitals
                                                                                                                      1. Clinics
                                                                                                                        1. Ambulatory Surgical Centers
                                                                                                                      2. Germany
                                                                                                                      3. France
                                                                                                                      4. Spain
                                                                                                                      5. Italy
                                                                                                                      6. Russia
                                                                                                                      7. Nordic
                                                                                                                      8. Benelux
                                                                                                                      9. Rest of Europe
                                                                                                                    2. APAC
                                                                                                                      1. APAC Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                        1. Surgery
                                                                                                                          1. Radiation Therapy
                                                                                                                            1. Chemotherapy
                                                                                                                              1. Targeted Therapy
                                                                                                                                1. Tumor Treating Field (TTF) Therapy
                                                                                                                                  1. Immunotherapy
                                                                                                                                  2. APAC Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                    1. Temozolomide
                                                                                                                                      1. Bevacizumab
                                                                                                                                        1. Lomustine
                                                                                                                                          1. Carmustine Wafers
                                                                                                                                            1. Others
                                                                                                                                            2. APAC Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                              1. Hospitals
                                                                                                                                                1. Clinics
                                                                                                                                                  1. Ambulatory Surgical Centers
                                                                                                                                                  2. China
                                                                                                                                                    1. China Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                      1. Surgery
                                                                                                                                                        1. Radiation Therapy
                                                                                                                                                          1. Chemotherapy
                                                                                                                                                            1. Targeted Therapy
                                                                                                                                                              1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                1. Immunotherapy
                                                                                                                                                                2. China Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                  1. Temozolomide
                                                                                                                                                                    1. Bevacizumab
                                                                                                                                                                      1. Lomustine
                                                                                                                                                                        1. Carmustine Wafers
                                                                                                                                                                          1. Others
                                                                                                                                                                          2. China Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                            1. Hospitals
                                                                                                                                                                              1. Clinics
                                                                                                                                                                                1. Ambulatory Surgical Centers
                                                                                                                                                                              2. Korea
                                                                                                                                                                              3. Japan
                                                                                                                                                                              4. India
                                                                                                                                                                              5. Australia
                                                                                                                                                                              6. Taiwan
                                                                                                                                                                              7. South East Asia
                                                                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                              1. Middle East and Africa Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                                                1. Surgery
                                                                                                                                                                                  1. Radiation Therapy
                                                                                                                                                                                    1. Chemotherapy
                                                                                                                                                                                      1. Targeted Therapy
                                                                                                                                                                                        1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                                          1. Immunotherapy
                                                                                                                                                                                          2. Middle East and Africa Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                                            1. Temozolomide
                                                                                                                                                                                              1. Bevacizumab
                                                                                                                                                                                                1. Lomustine
                                                                                                                                                                                                  1. Carmustine Wafers
                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                    2. Middle East and Africa Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                                                      1. Hospitals
                                                                                                                                                                                                        1. Clinics
                                                                                                                                                                                                          1. Ambulatory Surgical Centers
                                                                                                                                                                                                          2. UAE
                                                                                                                                                                                                            1. UAE Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                                                                              1. Surgery
                                                                                                                                                                                                                1. Radiation Therapy
                                                                                                                                                                                                                  1. Chemotherapy
                                                                                                                                                                                                                    1. Targeted Therapy
                                                                                                                                                                                                                      1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                                                                        1. Immunotherapy
                                                                                                                                                                                                                        2. UAE Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                                                                          1. Temozolomide
                                                                                                                                                                                                                            1. Bevacizumab
                                                                                                                                                                                                                              1. Lomustine
                                                                                                                                                                                                                                1. Carmustine Wafers
                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                  2. UAE Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                                                                                    1. Hospitals
                                                                                                                                                                                                                                      1. Clinics
                                                                                                                                                                                                                                        1. Ambulatory Surgical Centers
                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                      1. LATAM Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                                                                                                        1. Surgery
                                                                                                                                                                                                                                          1. Radiation Therapy
                                                                                                                                                                                                                                            1. Chemotherapy
                                                                                                                                                                                                                                              1. Targeted Therapy
                                                                                                                                                                                                                                                1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                                                                                                  1. Immunotherapy
                                                                                                                                                                                                                                                  2. LATAM Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                                                                                                    1. Temozolomide
                                                                                                                                                                                                                                                      1. Bevacizumab
                                                                                                                                                                                                                                                        1. Lomustine
                                                                                                                                                                                                                                                          1. Carmustine Wafers
                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                            2. LATAM Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                                                                                                              1. Hospitals
                                                                                                                                                                                                                                                                1. Clinics
                                                                                                                                                                                                                                                                  1. Ambulatory Surgical Centers
                                                                                                                                                                                                                                                                  2. Brazil
                                                                                                                                                                                                                                                                    1. Brazil Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                                                                                                                                      1. Surgery
                                                                                                                                                                                                                                                                        1. Radiation Therapy
                                                                                                                                                                                                                                                                          1. Chemotherapy
                                                                                                                                                                                                                                                                            1. Targeted Therapy
                                                                                                                                                                                                                                                                              1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                                                                                                                                1. Immunotherapy
                                                                                                                                                                                                                                                                                2. Brazil Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                                                                                                                                  1. Temozolomide
                                                                                                                                                                                                                                                                                    1. Bevacizumab
                                                                                                                                                                                                                                                                                      1. Lomustine
                                                                                                                                                                                                                                                                                        1. Carmustine Wafers
                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                          2. Brazil Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                                                                                                                                            1. Hospitals
                                                                                                                                                                                                                                                                                              1. Clinics
                                                                                                                                                                                                                                                                                                1. Ambulatory Surgical Centers
                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                                                                                                          Related Reports

                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                                                                                                                                                                          Buy Now

                                                                                                                                                                                                                                                                                          Purchase Benefits

                                                                                                                                                                                                                                                                                          • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                          • Completely customizable scope
                                                                                                                                                                                                                                                                                          • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                          • Dedicated account manager
                                                                                                                                                                                                                                                                                          • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                          • Permission to print the report

                                                                                                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                                                                                                          www.straitsresearch.com
                                                                                                                                                                                                                                                                                          © Copyright . All rights Reserved.